Affected by negative news that the company's stock may be subject to a “delisting risk warning,” Kindick's stock price fell to a halt by 20cm on October 12. Director General Kindick's office said, “The company has promptly disclosed relevant matters in accordance with the requirements of the Securities Regulatory Commission and the Shanghai Stock Exchange, and there is no other important information that has not been disclosed. As for the trivalent influenza vaccine, the company has already begun to distribute it. The specific marketing and sales time will depend on the progress of batch issuance.” Also, on the question of “the quadrivalent influenza vaccine is being phased out, and it won't be sold in the future,” Kindike said that at the beginning of every year, WHO will publish the influenza season situation in the northern hemisphere in the second half of the year, and the China Center for Disease Control and Prevention will also issue corresponding vaccination guidelines in July and August, depending on the situation in that year.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.